Summary – Ross has developed proprietary technology to mine microbiomes, already discovering 110,000+ novel small molecules with potential applications across pharmaceuticals, agriculture, and beyond. Why investors should tune in: – First-mover advantage in an untapped market – Technology validated by Los Alamos National Lab – Platform business model with multiple revenue streams – Potential to generate 4X the human knowledge on microbial molecules annually Ross brings exceptional credentials as a serial entrepreneur who’s built Inc. 500 companies and secured backing from DARPA, NIH, and major research institutions. WATCH ON: LinkedIn